Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.04 EUR
80.96 M EUR
1.03 B EUR
556.25 M
About DR. MARTENS PLC ORD GBP0.01
Sector
Industry
CEO
Kenneth Charles Wilson
Website
Headquarters
London
Founded
1945
ISIN
GB00BL6NGV24
FIGI
BBG00Z3H66X5
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 3U2 is featured.
Frequently Asked Questions
The current price of 3U2 is 0.84 EUR — it has decreased by −0.61% in the past 24 hours. Watch DR. MARTENS PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange DR. MARTENS PLC stocks are traded under the ticker 3U2.
3U2 stock has risen by 17.39% compared to the previous week, the month change is a 25.58% rise, over the last year DR. MARTENS PLC has showed a −25.66% decrease.
We've gathered analysts' opinions on DR. MARTENS PLC future price: according to them, 3U2 price has a max estimate of 1.14 EUR and a min estimate of 0.72 EUR. Watch 3U2 chart and read a more detailed DR. MARTENS PLC stock forecast: see what analysts think of DR. MARTENS PLC and suggest that you do with its stocks.
3U2 stock is 6.33% volatile and has beta coefficient of 2.53. Track DR. MARTENS PLC stock price on the chart and check out the list of the most volatile stocks — is DR. MARTENS PLC there?
Today DR. MARTENS PLC has the market capitalization of 795.24 M, it has decreased by −6.52% over the last week.
Yes, you can track DR. MARTENS PLC financials in yearly and quarterly reports right on TradingView.
DR. MARTENS PLC is going to release the next earnings report on May 29, 2025. Keep track of upcoming events with our Earnings Calendar.
3U2 earnings for the last half-year are −0.03 EUR per share, whereas the estimation was −0.03 EUR, resulting in a 0.00% surprise. The estimated earnings for the next half-year are 0.04 EUR per share. See more details about DR. MARTENS PLC earnings.
DR. MARTENS PLC revenue for the last half-year amounts to 389.84 M EUR, despite the estimated figure of 389.84 M EUR. In the next half-year revenue is expected to reach 588.54 M EUR.
3U2 net income for the last half-year is −24.98 M EUR, while the previous report showed 58.73 M EUR of net income which accounts for −142.54% change. Track more DR. MARTENS PLC financial stats to get the full picture.
DR. MARTENS PLC dividend yield was 2.91% in 2023, and payout ratio reached 36.22%. The year before the numbers were 4.10% and 45.34% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 4, 2024, the company has 2.63 K employees. See our rating of the largest employees — is DR. MARTENS PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. MARTENS PLC EBITDA is 186.27 M EUR, and current EBITDA margin is 22.65%. See more stats in DR. MARTENS PLC financial statements.
Like other stocks, 3U2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. MARTENS PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. MARTENS PLC technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. MARTENS PLC stock shows the sell signal. See more of DR. MARTENS PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.